These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 32113160)
1. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160 [TBL] [Abstract][Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366 [TBL] [Abstract][Full Text] [Related]
4. CDKN2A germline mutations in familial pancreatic cancer. Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511 [TBL] [Abstract][Full Text] [Related]
5. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients. Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325 [TBL] [Abstract][Full Text] [Related]
6. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595 [TBL] [Abstract][Full Text] [Related]
7. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB; J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299 [TBL] [Abstract][Full Text] [Related]
8. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in Japanese familial pancreatic cancer patients. Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808 [TBL] [Abstract][Full Text] [Related]
12. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J; Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971 [TBL] [Abstract][Full Text] [Related]
14. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589 [TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic Overbeek KA; Rodríguez-Girondo MD; Wagner A; van der Stoep N; van den Akker PC; Oosterwijk JC; van Os TA; van der Kolk LE; Vasen HFA; Hes FJ; Cahen DL; Bruno MJ; Potjer TP J Med Genet; 2021 Apr; 58(4):264-269. PubMed ID: 32482799 [TBL] [Abstract][Full Text] [Related]
19. Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas. Harinck F; Kluijt I; van der Stoep N; Oldenburg RA; Wagner A; Aalfs CM; Sijmons RH; Poley JW; Kuipers EJ; Fockens P; van Os TA; Bruno MJ J Med Genet; 2012 Jun; 49(6):362-5. PubMed ID: 22636603 [TBL] [Abstract][Full Text] [Related]